Kiaxone S 500mg/250mg Injection
Marketer
Alicanto Drugs Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Kiaxone S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administration must be under a physician's direct supervision; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Kiaxone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Kiaxone S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Kiaxone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kiaxone S 500mg/250mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Kiaxone S 500mg/250mg Injection works:
Kiaxone S 500mg/250mg injection unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone combats bacterial infection by disrupting the synthesis of their protective cell walls, while Sulbactam counters bacterial resistance, thereby amplifying Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Kiaxone S 500mg/250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Kiaxone S (500mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Kiaxone S 500mg/250mg Injection necessitates prudence while breastfeeding. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Kiaxone S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Kiaxone S 500mg/250mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The use of Kiaxone S 500mg/250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Kiaxone S 500mg/250mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Kiaxone S 500mg/250mg Injection :
Omit a scheduled Kiaxone S 500mg/250mg Injection? Seek medical advice immediately.
Facts to Know About Kiaxone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Antimicrobial agents |
3,018 People bought this recently